{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:06:17Z","timestamp":1785182777889,"version":"3.55.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.path.2026.02.011","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:19:51Z","timestamp":1781126391000},"page":"445-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathologic Assessment and Staging Cancers of Digestive Organs in the Era of Neoadjuvant Therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Monika","family":"Vyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti M.","family":"Karamchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2017.87","article-title":"Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy","volume":"31","author":"Pai","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2026.02.011_bib2","unstructured":"Burgart LJ, Chopp WV, Jain D. Protocol for the Examination of Specimens From Patients With Carcinoma of the Esophagus. Available at: https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates.Version:4.2.0.1, Protocol Posting Date: 2022."},{"key":"10.1016\/j.path.2026.02.011_bib3","unstructured":"Jain D, Chopp WV, Graham RP, et al. Protocol for the Examination of Resection Specimens from Patients with Primary Carcinoma of the Colon and\/\/or Rectum. Available at: https:\/\/www.cap.org\/protocols-and-guidelines\/cancer-reporting-tools\/cancer-protocol-templates. Version: 4.4.0.1, Protocol Posting Date: September 2025."},{"issue":"28","key":"10.1016\/j.path.2026.02.011_bib4","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1200\/JCO.24.01160","article-title":"Management of locally advanced rectal cancer: ASCO guideline","volume":"42","author":"Scott","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib5","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"10.1016\/j.path.2026.02.011_bib6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/OP-24-00550","article-title":"Management of locally advanced rectal cancer: ASCO guideline clinical insights","volume":"21","author":"Scott","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"25","key":"10.1016\/j.path.2026.02.011_bib9","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.5858\/arpa.2017-0475-RA","article-title":"A review of current challenges in colorectal cancer reporting","volume":"143","author":"Dawson","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000478-200203000-00009","article-title":"Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit","volume":"26","author":"Nagtegaal","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.2002.07.010","article-title":"Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control","volume":"20","author":"Nagtegaal","year":"2002","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0959-8049(02)00056-4","article-title":"The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview","volume":"38","author":"Nagtegaal","year":"2002","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1200\/JCO.2007.12.7027","article-title":"What is the role for the circumferential margin in the modern treatment of rectal cancer?","volume":"26","author":"Nagtegaal","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5455\/medarh.2017.71.434-438","article-title":"Introduction to total mesorectal excision","volume":"71","author":"Delibegovic","year":"2017","journal-title":"Med Arch"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jcp.2006.043802","article-title":"The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment","volume":"60","author":"Parfitt","year":"2007","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.0007-1323.2001.02024.x","article-title":"Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer","volume":"89","author":"Wibe","year":"2002","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib18","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cam4.1662","article-title":"Circumferential resection margin as a prognostic factor after rectal cancer surgery: a large population-based retrospective study","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/DCR.0000000000000171","article-title":"A circumferential resection margin of 1 mm is a negative prognostic factor in rectal cancer patients with and without neoadjuvant chemoradiotherapy","volume":"57","author":"Park","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.path.2026.02.011_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(03)01248-8","article-title":"Training and quality assurance for rectal cancer: 20 years of data is enough","volume":"4","author":"Quirke","year":"2003","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/codi.12608","article-title":"Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: implications for treatment decisions","volume":"16","author":"Smith","year":"2014","journal-title":"Colorectal Dis"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1097-0142(19950801)76:3<388::AID-CNCR2820760307>3.0.CO;2-Y","article-title":"Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery","volume":"76","author":"Shirouzu","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02048158","article-title":"Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method","volume":"37","author":"Morikawa","year":"1994","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3748\/wjg.v11.i3.319","article-title":"Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin","volume":"11","author":"Zhao","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.path.2026.02.011_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anndiagpath.2015.10.008","article-title":"The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes","volume":"20","author":"Yegen","year":"2016","journal-title":"Ann Diagn Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib26","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/bjs.10218","article-title":"Prognostic significance of lymph node yield in ypN0 rectal cancer","volume":"103","author":"Raoof","year":"2016","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jclinpath-2016-203995","article-title":"Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy","volume":"70","author":"Xu","year":"2017","journal-title":"J Clin Pathol"},{"issue":"16","key":"10.1016\/j.path.2026.02.011_bib28","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/cncr.25973","article-title":"Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma","volume":"117","author":"Tsai","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/DCR.0b013e3181fd677d","article-title":"The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery","volume":"54","author":"Klos","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib30","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ejso.2010.09.007","article-title":"Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification","volume":"36","author":"Dekker","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.path.2026.02.011_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5858\/2001-125-0642-GS","article-title":"GEWF solution","volume":"125","author":"Newell","year":"2001","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/DCR.0b013e3182a84eba","article-title":"Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"57","author":"Smith","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1463-1318.2011.02761.x","article-title":"Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?","volume":"14","author":"Perez","year":"2012","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jso.22073","article-title":"The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy","volume":"105","author":"Roy","year":"2012","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1874375700903020091","article-title":"Histopathology of colorectal cancer after neoadjuvant chemoradiation therapy","volume":"3","author":"O\u2019Neil","year":"2009","journal-title":"Open Pathol J"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000478-200402000-00009","article-title":"Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome","volume":"28","author":"Shia","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0b013e318200cf78","article-title":"Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy","volume":"35","author":"Shia","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000478-200207000-00004","article-title":"Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy","volume":"26","author":"Shia","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.path.2026.02.011_bib39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijsu.2014.07.267","article-title":"Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer","volume":"12","author":"Bhatti","year":"2014","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41379-019-0344-3","article-title":"Challenges with colorectal cancer staging: results of an international study","volume":"33","author":"Karamchandani","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/SLA.0b013e3181bdfc27","article-title":"Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation","volume":"251","author":"Smith","year":"2010","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2559.2011.03888.x","article-title":"Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer","volume":"59","author":"Lindebjerg","year":"2011","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib44","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1186\/s12885-021-08922-1","article-title":"Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data","volume":"21","author":"Li","year":"2021","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.path.2026.02.011_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.29355","article-title":"Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients","volume":"137","author":"Maas","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.path.2026.02.011_bib47","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1002\/onco.13707","article-title":"College of American pathologists tumor regression grading system for long-term outcome in patients with locally advanced rectal cancer","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"issue":"34","key":"10.1016\/j.path.2026.02.011_bib48","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1200\/JCO.2005.02.1329","article-title":"Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer","volume":"23","author":"Rodel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/DCR.0000000000000266","article-title":"American joint committee on cancer and college of American Pathologists regression grade: a new prognostic factor in rectal cancer","volume":"58","author":"Mace","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"22","key":"10.1016\/j.path.2026.02.011_bib50","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-023-02458-w","article-title":"Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma","volume":"130","author":"Clements","year":"2024","journal-title":"Br J Cancer"},{"issue":"19","key":"10.1016\/j.path.2026.02.011_bib52","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","article-title":"Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival","volume":"23","author":"Berger","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3892\/ol.2022.13292","article-title":"Progress in neoadjuvant therapy for gastric cancer","volume":"23","author":"Su","year":"2022","journal-title":"Oncol Lett"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14123026","article-title":"Neoadjuvant chemoradiotherapy for locally advanced gastric cancer: where are we at?","volume":"14","author":"Yeh","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"27","key":"10.1016\/j.path.2026.02.011_bib55","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction","volume":"32","author":"Davies","year":"2014","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib56","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cncr.20916","article-title":"Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation","volume":"103","author":"Chirieac","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib57","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/PAS.0000000000000420","article-title":"Predictors of disease recurrence and survival in esophageal adenocarcinomas with complete response to neoadjuvant therapy","volume":"39","author":"Agoston","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib58","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11605-015-2821-4","article-title":"Lymph node harvest during esophagectomy is not influenced by use of neoadjuvant therapy or clinical disease stage","volume":"19","author":"Luna","year":"2015","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib59","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s13193-020-01156-w","article-title":"The value of lymphadenectomy post-neoadjuvant therapy in carcinoma esophagus: a review","volume":"11","author":"Nusrath","year":"2020","journal-title":"Indian J Surg Oncol"},{"issue":"16","key":"10.1016\/j.path.2026.02.011_bib60","doi-asserted-by":"crossref","first-page":"22497","DOI":"10.18632\/oncotarget.8113","article-title":"Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.pas.0000174011.29816.fa","article-title":"Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett\u2019s-associated adenocarcinoma","volume":"30","author":"Hornick","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib62","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1158\/1078-0432.CCR-04-1840","article-title":"Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma","volume":"11","author":"Chirieac","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib63","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/SLA.0000000000000689","article-title":"Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior","volume":"260","author":"Nafteux","year":"2014","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jso.27774","article-title":"Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma","volume":"130","author":"Mitchell","year":"2024","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/his.15364","article-title":"Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome","volume":"86","author":"Dodington","year":"2025","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib66","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/cncr.22179","article-title":"The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation","volume":"107","author":"Wang","year":"2006","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2026.02.011_bib67","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cncr.21693","article-title":"The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation","volume":"106","author":"Gu","year":"2006","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.path.2026.02.011_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17142400","article-title":"Impact of neoadjuvant chemotherapy on survival outcomes in gastric signet-ring cell carcinoma","volume":"17","author":"Sorrenti","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.path.2026.02.011_bib69","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib70","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/PAS.0000000000001797","article-title":"Florid foreign body-type giant cell response to Keratin is associated with improved overall survival in patients receiving preoperative therapy for esophageal squamous cell carcinoma","volume":"45","author":"Chen","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.51821\/85.2.8316","article-title":"Immature squamous metaplasia of esophageal glands associated with squamous cell carcinoma","volume":"85","author":"Verset","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"issue":"11","key":"10.1016\/j.path.2026.02.011_bib72","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/PAS.0000000000000255","article-title":"Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches","volume":"38","author":"Karamitopoulou","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib73","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.pas.0000213312.36306.cc","article-title":"Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome","volume":"31","author":"Wu","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib75","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2009.123","article-title":"Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas","volume":"22","author":"Langer","year":"2009","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.path.2026.02.011_bib76","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s11605-016-3177-0","article-title":"Pathologic complete response is an independent predictor of improved survival following neoadjuvant chemoradiation for esophageal adenocarcinoma","volume":"20","author":"Alnaji","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib77","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1245\/s10434-010-0995-2","article-title":"Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor","volume":"17","author":"Tong","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.path.2026.02.011_bib78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant therapy for pancreatic cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.path.2026.02.011_bib79","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","article-title":"Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas","volume":"127","author":"Evans","year":"1992","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN Clinical Practice Guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"34","key":"10.1016\/j.path.2026.02.011_bib81","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1200\/JCO.21.01220","article-title":"Value of neoadjuvant radiation therapy in the management of pancreatic adenocarcinoma","volume":"39","author":"Hall","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib82","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cncr.26243","article-title":"Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation","volume":"118","author":"Estrella","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib83","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/cncr.26651","article-title":"Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome","volume":"118","author":"Chatterjee","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.path.2026.02.011_bib84","doi-asserted-by":"crossref","first-page":"838","DOI":"10.5858\/arpa.2019-0477-RA","article-title":"Pathology of treated pancreatic ductal adenocarcinoma and its clinical implications","volume":"144","author":"Nagaria","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib85","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/PAS.0000000000001853","article-title":"Pathologic examination of pancreatic specimens resected for treated pancreatic ductal adenocarcinoma: recommendations from the pancreatobiliary pathology society","volume":"46","author":"Wang","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000267","article-title":"Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages","volume":"7","author":"Gillen","year":"2010","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.path.2026.02.011_bib87","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/bjs.5397","article-title":"Redefining the R1 resection in pancreatic cancer","volume":"93","author":"Verbeke","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.path.2026.02.011_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-8-5","article-title":"Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor","volume":"8","author":"Westgaard","year":"2008","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.path.2026.02.011_bib89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0000000000000491","article-title":"Superior mesenteric artery margin of posttherapy pancreaticoduodenectomy and prognosis in patients with pancreatic ductal adenocarcinoma","volume":"39","author":"Liu","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2026.02.011_bib90","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.18632\/oncotarget.13950","article-title":"Superior mesenteric artery margin in pancreaticoduodenectomy for pancreatic adenocarcinoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib91","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/PAS.0000000000000165","article-title":"Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors","volume":"38","author":"Adsay","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"10.1016\/j.path.2026.02.011_bib92","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1002\/cncr.26717","article-title":"Histologic tumor involvement of superior mesenteric vein\/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation","volume":"118","author":"Wang","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2026.02.011_bib93","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/his.12732","article-title":"The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy","volume":"68","author":"Fischer","year":"2016","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib94","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jclinpath-2016-203604","article-title":"The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes","volume":"69","author":"Kalimuthu","year":"2016","journal-title":"J Clin Pathol"},{"issue":"8","key":"10.1016\/j.path.2026.02.011_bib95","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0000000000000887","article-title":"Prognostic significance of new AJCC tumor stage in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy","volume":"41","author":"Chatterjee","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0b013e31824104c5","article-title":"Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"36","author":"Chatterjee","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib97","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0b013e318240c1c0","article-title":"Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy","volume":"36","author":"Chatterjee","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.path.2026.02.011_bib98","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/PAS.0000000000000738","article-title":"Validation of a proposed tumor regression grading scheme for pancreatic ductal adenocarcinoma after neoadjuvant therapy as a prognostic indicator for survival","volume":"40","author":"Lee","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib99","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000001601","article-title":"A critical assessment of postneoadjuvant therapy pancreatic cancer regression grading schemes with a proposal for a novel approach","volume":"45","author":"Chou","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74067-z","article-title":"Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems","volume":"10","author":"Matsuda","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.path.2026.02.011_bib101","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jclinpath-2016-203947","article-title":"Regression grading in neoadjuvant treated pancreatic cancer: an interobserver study","volume":"70","author":"Kalimuthu S","year":"2017","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.02.011_bib102","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/PAS.0000000000002013","article-title":"Integrated pathologic score effectively stratifies patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and pancreaticoduodenectomy","volume":"47","author":"Sohn","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2026.02.011_bib103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"10.1016\/j.path.2026.02.011_bib104","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2559.2009.03292.x","article-title":"Rectal cancer staging post neoadjuvant therapy--how should the changes be assessed?","volume":"54","author":"Bateman","year":"2009","journal-title":"Histopathology"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918126000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918126000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:38:00Z","timestamp":1785181080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918126000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1875918126000255"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2026.02.011","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathologic Assessment and Staging Cancers of Digestive Organs in the Era of Neoadjuvant Therapy","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2026.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}